Trial · NCT06795672
Tele-rehabilitation for Cognitive Disorders
NCT06795672, Not applicable, Terminated, Universita di Verona
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Tele-rehabilitation for Cognitive Disorders. Trials, record NCT06795672. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06795672
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Tele-rehabilitation for Cognitive Disorders
- NCT number
- NCT06795672
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 23 participants, actual
- Lead sponsor
- Universita di Verona
- Conditions
- Rehabilitation, Stroke, Telerehabilitation, Telemedicine
- Interventions
- Telerehabilitation, Traditional in-person rehabilitation.
- First posted
- 2025-01-28
- Last updated
- 2025-01-28
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Trail Making Test Part B (TMT-B) | From enrollment to the end of treatment and 2 months until the end of treatment | Used as a measure of attentional set-shifting and mental flexibility. Time needed to complete the tasks is recorded. |
| Secondary | The Trail Making Test - A (TMT-A) | From enrollment to the end of treatment and 2 months until the end of treatment | Used as a measure of psychomotor speed and visual search/attention skills |
| Secondary | 15 Words of Rey | From enrollment to the end of treatment and 2 months until the end of treatment | To assess verbal learning ability and long-term verbal memory (IMMEDIATE RECALL: score ranging from 0 to 75. DELAYED RECALL: score ranging from 0 to 15). |
| Secondary | Memory with interference - ENB 2 | From enrollment to the end of treatment and 2 months until the end of treatment | to assess working memory through the memorization of letter triplets alongside a distracting task lasting 10 seconds in the first part and 30 seconds in the second. The maximum obtainable score is 9 for both parts of the test. |
| Secondary | Dual task test | From enrollment to the end of treatment and 2 months until the end of treatment | Dual Task to assess the ability to perform two tasks simultaneously (one verbal and one visuomotor) |
| Secondary | Elithorn's Perceptual Maze Test | From enrollment to the end of treatment and 2 months until the end of treatment | to investigate problem-solving abilities. |
| Secondary | Stroop Test | From enrollment to the end of treatment and 2 months until the end of treatment | to assess the speed and accuracy of automatic response inhibition. |
| Secondary | Functional Independence Measure (FIM) | From enrollment to the end of treatment and 2 months until the end of treatment | To evaluate the degree of disability. |
| Secondary | Hospital Anxiety and Depression Scale | From enrollment to the end of treatment and 2 months until the end of treatment | to assess the presence of depression and anxiety. |
| Secondary | Short Form Health Survey 36 (SF-36) | From enrollment to the end of treatment and 2 months until the end of treatment | to evaluate quality of life. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Trail Making Test B | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06795672
GET https://conductscience.org/api/trials/v1/NCT06795672/registered